Empfield James R.
CIK 0001665430
EVP, Drug Discovery
Filings
4
Latest Mar 12, 2024
Issuers covered
1
Showing
4 of 4
Page 1
Track record
3 of 3 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 3 | 0% | -14.7% | -15.6% | -13.0% | -15.6% |
| 90 days | 3 | 100% | +3.0% | +0.9% | +7.4% | +0.9% |
| 180 days | 3 | 0% | -24.6% | -22.7% | -22.7% | -28.4% |
| 365 days | 3 | 0% | -20.5% | -19.3% | -19.3% | -22.8% |
Issuers
Companies where Empfield James R. has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| XENE | Xenon Pharmaceuticals Inc. | 4 | Mar 12, 2024 |
All filings
4 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|